(10 May 2024, Singapore) Templewater, a leading private equity firm specializing in mid-market control buyout opportunities in the Asia Pacific, is pleased to announce that its portfolio company, TW Pengu Holdings Limited (“TWPHL”), has acquired Singapore Breast Surgery Center (“SBSC”), Central Luzon Integrated Oncology Centre (“CLIOC”) and Can-Care from TE Asia Healthcare, a pan-Asia focused healthcare services company.
TWPHL’s objective is to develop a premier oncology group in Asia to attract leading doctors and practices across multiple jurisdictions to enable patients to receive the best treatment and services across all stages of the treatment journey. With Templewater’s support, it has expanded its portfolio to include well-known oncology businesses that provide the highest standards of patient service.
In December 2023, TWPHL was set up following the acquisition of OncoCare, one of the most established private oncology specialist centers in Singapore, and Novena Heart Centre, one of the leading private cardiology care practices in Singapore. Additionally in February 2024, OncoCare announced the execution of a Letter of Intent with Thomson Hospital Kota Damansara for exclusive negotiations regarding the provision of oncology services in Kuala Lumpur, Malaysia.
Today, TWPHL announces three additional acquisitions:
· Singapore Breast Surgery Center (“SBSC”) is an integrated breast cancer care group in Singapore, through its brands Solis and Luma, covering the entire breast cancer theragnostic process including screening, diagnostic imaging, pathology and surgery services.
· Central Luzon Integrated Oncology Centre (“CLIOC”) is a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services.
· Can-Care is a retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets.
Templewater is committed to support TWPHL in achieving its goals to establish itself as the premier oncology focused care group in Asia. We are excited about the future of TWPHL and its potential to make a meaningful impact on the lives of patients across the region. As it expands its footprint, enhances patient offering, and attracts top healthcare talent, Templewater and TWPHL are poised to revolutionize oncology care in Asia and set new standards of excellence in the industry.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Templewater
Jason Li
Investor Relations
ir@templewater.com
+852 3187 5000
About Templewater Group
Founded in 2018, the Templewater Group (“Templewater”) is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate.
Templewater’s private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific. With global direct investments and buyout experience across sectors, Templewater actively partners with management teams to implement value creation tools and best practices, helping portfolio companies achieve their full potential. The firm currently manages capital on behalf of leading institutional investors.
To learn more about Templewater, please visit www.templewater.com
About SBSC
Founded in 2020 in Singapore, SBSC is a one-stop breast cancer care group in Singapore, through its brands Solis and Luma, covering all stages of breast cancer theragnostic process including screening, diagnostic and surgical treatment solutions. The group boasts seven breast surgeons, three radiologists, and one in-house pathologist, with cutting-edge in-house imaging facilities and day surgery operating theatres.
To learn more about Solis, please visit www.solis.sg
To Learn more about Luma, please visit www.luma.sg
About CLIOC
Founded in 2017, CLIOC is an independent cancer clinic providing tomotherapy and chemotherapy services. It offers services from cancer screening, identification, imaging, diagnosis, and cancer treatments.
To learn more about CLIOC, please visit www.clioc.com.ph
About Can-Care
Established in 1997, Can-Care provides personalized post cancer care products and services to patients. Led by a team of professionals with nursing and medical backgrounds and operating out of four outlets, Can-Care provides personalized post treatment care products for newly diagnosed cancer patients and cancer survivors.
To learn more about Can-Care, please visit www.cancare.asia
